Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Michael Lyudmer"'
Autor:
Prachi Anand, Petr Filipenko, Jeannette Huaman, Michael Lyudmer, Marouf Hossain, Carolina Santamaria, Kelly Huang, Olorunseun O. Ogunwobi, Mandë Holford
Publikováno v:
Marine Drugs, Vol 17, Iss 10, p 587 (2019)
Increasingly cancer is being viewed as a channelopathy because the passage of ions via ion channels and transporters mediate the regulation of tumor cell survival, death, and motility. As a result, a potential targeted therapy for cancer is to use ve
Externí odkaz:
https://doaj.org/article/2b428e0cf1d54c06a0e4a0a927764873
Autor:
Alexa M. Choy, Michael Lyudmer, Steven Su, Helen E. Remotti, Jason E. Zucker, Daniela Jodorkovsky
Publikováno v:
ACG Case Reports Journal. 10:e01002
Autor:
Michael Lyudmer, Sriram Sankaranarayanan, Ari J. Holtzman, Benjamin J. Levy, Konrad I. Gruson, Eloy Tabeayo
Publikováno v:
Journal of the American Academy of Orthopaedic Surgeons. 28:e295-e303
INTRODUCTION Plain radiographs of the shoulder are routinely obtained for patients presenting with atraumatic shoulder pain, although the diagnostic utility of this imaging modality is unclear. Despite this, patients often prefer to obtain radiograph
Survival analysis of patients with early and standard onset colorectal cancer: A single center study
Autor:
Dhruv Patel, Catarina Martins Maia, Michael Lyudmer, Seda Tolu, Adel Chergui, Riya Jayesh Patel, So Yeon Kim, Radhika Gali, Ana Acuna Villaorduna, Sanjay Goel
Publikováno v:
Journal of Clinical Oncology. 40:e15512-e15512
e15512 Background: While more aggressive clinical/pathological features have been consistently described in between patients with early-onset (EO) and standard-onset (SO) colorectal cancer (CRC), survival data have been conflicting. While some studie
Autor:
Jeannette Huaman, Michael Lyudmer, Carolina Santamaria, Prachi Anand, Marouf Hossain, Kelly Huang, Olorunseun O. Ogunwobi, Petr Filipenko, Mandë Holford
Publikováno v:
Marine Drugs, Vol 17, Iss 10, p 587 (2019)
Marine Drugs
Volume 17
Issue 10
Marine Drugs
Volume 17
Issue 10
Increasingly cancer is being viewed as a channelopathy because the passage of ions via ion channels and transporters mediate the regulation of tumor cell survival, death, and motility. As a result, a potential targeted therapy for cancer is to use ve
Autor:
Janki Patel, Jesus Del Santo Anampa Mesias, Michael Lyudmer, Stephanie Shamir, Lisa Phuong, Junwen Deng, Nadia Baka, Jessica Goldman, Alvaro Alvarez Soto
Publikováno v:
Journal of Clinical Oncology. 39:e13026-e13026
e13026 Background: BC measurement can distinguish adipose tissue distribution, as well as the quantity and quality of muscle. Dysregulation in the mammalian target of rapamycin (mTOR) signaling pathway is associated with obesity and its related disea
Autor:
Michael Lyudmer, Janki Patel, Jesus Del Santo Anampa Mesias, Lisa Phuong, Junwen Deng, Alvaro Alvarez Soto, Stephanie Shamir, Nadia Baka, Jessica Goldman
Publikováno v:
Journal of Clinical Oncology. 39:e13033-e13033
e13033 Background: CDKIs with endocrine therapy (ET) is first-line treatment in HR+/HER2- MBC. Mouse models have shown that CDKIs prevent pRB phosphorylation in the mediobasal hypothalamus, a pathway hyper-activated in diet-induced obesity; and CDKIs
Autor:
Olorunseun O. Ogunwobi, Carolina Santamaria, Michael Lyudmer, Prachi Anand, Jeannette Huaman, Kelly Huang, Mandë Holford, Marouf Hossain, Petr Filipenko
A strategy for treating the most common type of liver cancer, hepatocellular carcinoma (HCC) applies a targeted therapy using venom peptides that are selective for ion channels and transporters overexpressed in tumor cells. Here, we report selective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::847742029f9a9fc4a8ab9d002cf4c1ab
https://doi.org/10.1101/518340
https://doi.org/10.1101/518340
Autor:
Sanjay Goel, Devika Rao, Seda Serra Tolu, Ana Acuna-Villaorduna, Michael Lyudmer, Andreas Kaubisch, Tarek N. Elrafei, Jennifer W. Chuy, Riya Jayesh Patel, Adel Chergui
Publikováno v:
Journal of Clinical Oncology. 39:141-141
141 Background: Differences in incidence, clinical features, and survival between early-onset (EO) and standard-onset (SO) colorectal cancer (CRC) are well-established. Factors associated with longer survival have not been reported. We aim to determi
Autor:
Seda Serra Tolu, Riya Jayesh Patel, Sanjay Goel, Ana Acuna-Villaorduna, Michael Lyudmer, Devika Rao, Jennifer W. Chuy, Andreas Kaubisch, Tarek N. Elrafei, Adel Chergui
Publikováno v:
Journal of Clinical Oncology. 39:21-21
21 Background: Globally, the incidence of early-onset colorectal cancer has risen. Racial disparities in colorectal cancer (CRC) are well-described, however data in EO by race/ethnicity is lacking. We aim to compare the presenting features, treatment